Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Comments

Loading...

Chugai Pharmaceutical

CHGCYOTCPK

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$25.49

1.074.38%

At close: -

$24.27

-1.22-4.79%

After Hours: Feb 19, 4:00 PM EDT

Chugai Pharmaceutical (CHGCY) Forecast

News

Earnings Chugai Pharmaceutical (CHGCY) Options Guidance Dividends Analyst Ratings Insider Trades Government Trades Short Interest

Latest news for Chugai Pharmaceutical (OTC:CHGCY) Stock

Chugai Pharmaceutical Stock (OTC: CHGCY)

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Monday, December 12, 2022

Short Volatility Alert: Chugai Pharm Co
Christopher Sappo

Thursday, March 17, 2022

The Daily Biotech Pulse: AbbVie's Rinvoq Gets Label Expansion, AstraZeneca COVID Antibody Cocktail Authorized By UK Regulator, Stealth Touts Positive Data
Shanthi Rexaline

Tuesday, January 12, 2021

Global Markets Remain Mixed Amid China's Rally, Bitcoin Recovers
Mohit Manghnani

Tuesday, March 24, 2020

Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
Stocks That Hit 52-Week Highs On Tuesday
Benzinga Insights

Tuesday, February 11, 2020

Stocks That Hit 52-Week Highs On Tuesday
Lisa Levin

Tuesday, February 04, 2020

Stocks That Hit 52-Week Highs On Tuesday
Lisa Levin

Monday, February 03, 2020

Stocks That Hit 52-Week Highs On Monday
Lisa Levin

Thursday, January 30, 2020

Stocks That Hit 52-Week Highs On Thursday
Lisa Levin

Friday, January 24, 2020

Stocks That Hit 52-Week Highs On Friday
Lisa Levin

Tuesday, January 21, 2020

Stocks That Hit 52-Week Highs On Tuesday
Lisa Levin

Friday, January 17, 2020

Stocks That Hit 52-Week Highs On Friday
Lisa Levin

Thursday, January 09, 2020

Stocks That Hit 52-Week Highs On Thursday
Lisa Levin

Tuesday, December 17, 2019

Stocks That Hit 52-Week Highs On Tuesday
Lisa Levin

Tuesday, December 10, 2019

Stocks That Hit 52-Week Highs On Tuesday
Lisa Levin

Wednesday, October 30, 2019

The Daily Biotech Pulse: Novartis Program Placed On Partial Clinical Hold, Adcom Snub For Amag, Amgen Earnings
Shanthi Rexaline

Thursday, September 12, 2019

The Daily Biotech Pulse: Ardelyx Awaits Ruling On Constipation Drug, Double Dose Of Good News For Roche, Tocagen Flunks Brain Cancer Study
Shanthi Rexaline

Tuesday, July 30, 2019

New Stocks that Broke Through 52-Week Highs Tuesday Morning
Lisa Levin

Saturday, March 05, 2016

Chugai Announces Phase II Global Study Results of Nemolizumab in Late-breaking Research Forums at AAD
Benzinga

Popular Channels

PreMarket Playbook
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved